188 related articles for article (PubMed ID: 17498557)
21. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
[TBL] [Abstract][Full Text] [Related]
22. ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females.
Yin Z; Su M; Li X; Li M; Ma R; He Q; Zhou B
J Exp Clin Cancer Res; 2009 Dec; 28(1):153. PubMed ID: 20003391
[TBL] [Abstract][Full Text] [Related]
23. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
[TBL] [Abstract][Full Text] [Related]
24. Significant association of XPD Asp312Asn polymorphism with breast cancer in Taiwanese patients.
Wang HC; Liu CS; Wang CH; Tsai RY; Tsai CW; Wang RF; Chang CH; Chen YS; Chiu CF; Bau DT; Huang CY
Chin J Physiol; 2010 Apr; 53(2):130-5. PubMed ID: 21793320
[TBL] [Abstract][Full Text] [Related]
25. The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population.
Yin J; Li J; Ma Y; Guo L; Wang H; Vogel U
Cancer Lett; 2005 Jun; 223(2):219-26. PubMed ID: 15896456
[TBL] [Abstract][Full Text] [Related]
26. HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Wang H; Yue L; Liang D; Wang C; Li X; Song T
Mutat Res; 2011 Aug; 713(1-2):1-7. PubMed ID: 21601580
[TBL] [Abstract][Full Text] [Related]
27. XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients.
El-Tokhy MA; Hussein NA; Bedewy AM; Barakat MR
Hematology; 2014 Oct; 19(7):397-403. PubMed ID: 24284041
[TBL] [Abstract][Full Text] [Related]
28. DNA repair gene XRCC1 and XPD polymorphisms and the risk of idiopathic azoospermia in a Chinese population.
Gu A; Ji G; Liang J; Xia Y; Lu N; Wu B; Wang W; Song L; Wang S; Wang X
Int J Mol Med; 2007 Nov; 20(5):743-7. PubMed ID: 17912469
[TBL] [Abstract][Full Text] [Related]
29. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
[TBL] [Abstract][Full Text] [Related]
31. Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.
Wu Y; Yang Y
Tumour Biol; 2014 Jun; 35(6):5245-57. PubMed ID: 24504678
[TBL] [Abstract][Full Text] [Related]
32. ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis.
Chen B; Zhou Y; Yang P; Wu XT
J Cancer Res Clin Oncol; 2011 Jun; 137(6):939-46. PubMed ID: 20981556
[TBL] [Abstract][Full Text] [Related]
33. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
Xiao F; Pu J; Wen Q; Huang Q; Zhang Q; Huang B; Huang S; Lan A; Zhang Y; Li J; Zhao D; Shen J; Wu H; He Y; Li H; Yang X
Oncotarget; 2017 Jul; 8(29):48488-48506. PubMed ID: 28489582
[TBL] [Abstract][Full Text] [Related]
34. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
36. Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK.
Affatato AA; Wolfe KJ; Lopez MS; Hallberg C; Ammenheuser MM; Abdel-Rahman SZ
Environ Mol Mutagen; 2004; 44(1):65-73. PubMed ID: 15199548
[TBL] [Abstract][Full Text] [Related]
37. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis.
Feng Z; Ni Y; Dong W; Shen H; Du J
Mol Biol Rep; 2012 Jan; 39(1):57-69. PubMed ID: 21614524
[TBL] [Abstract][Full Text] [Related]
38. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.
Yan Y; Liang H; Light M; Li T; Deng Y; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1907-15. PubMed ID: 24101192
[TBL] [Abstract][Full Text] [Related]
39. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.
Sturgis EM; Dahlstrom KR; Spitz MR; Wei Q
Arch Otolaryngol Head Neck Surg; 2002 Sep; 128(9):1084-8. PubMed ID: 12220217
[TBL] [Abstract][Full Text] [Related]
40. The ERCC2/XPD Lys751Gln polymorphism affects DNA repair of benzo[a]pyrene induced damage, tested in an in vitro model.
Xiao S; Cui S; Lu X; Guan Y; Li D; Liu Q; Cai Y; Jin C; Yang J; Wu S; van der Straaten T
Toxicol In Vitro; 2016 Aug; 34():300-308. PubMed ID: 27139774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
